ACADIAN ASSET MANAGEMENT LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2022$63
-100.0%
17,256
-90.8%
0.00%
-100.0%
Q3 2022$138,000
+1625.0%
187,034
+1995.6%
0.00%
Q1 2022$8,000
-68.0%
8,925
+144.9%
0.00%
Q2 2021$25,0003,645
+3545.0%
0.00%
Q4 2017$01000.0%0.00%
Q3 2017$0
-100.0%
100
-98.4%
0.00%
Q4 2016$31,000
-89.8%
6,422
-64.6%
0.00%
-100.0%
Q2 2015$303,00018,1520.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2023
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders